| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former 10% Owner | 10% Owner
3 companies
Column Group Ii, LP is a 10% Owner at RCUS with holdings across 3 companies. Recent SEC Form 4 filings include 16 buys and 28 sells.
Estimated insider holdings value: $53.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 25, 2022 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Buy | 1,900 | $12.45 | $23,664.31 | +0.1% | +93.5% | +47.0% | |
| May 25, 2022 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Buy | 1,900 | $12.45 | $23,664.31 | +0.1% | +93.5% | +47.0% | |
| May 24, 2022 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Buy | 26,550 | $12.19 | $323,745.09 | +1.1% | +110.2% | +67.4% | |
| May 24, 2022 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Buy | 26,550 | $12.19 | $323,745.09 | +1.1% | +110.2% | +67.4% | |
| May 10, 2022 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Buy | 1,250,000 | $10.67 | $13,339,375.00 | New | +95.7% | +77.4% | |
| May 10, 2022 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Buy | 1,250,000 | $10.67 | $13,339,375.00 | New | +95.7% | +77.4% | |
| Sep 27, 2021 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sale+OE | 9,239 | $34.57 | $319,397.39 | -100% | +5.9% | -30.8% | |
| Sep 15, 2021 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sell | 181,211 | $37.01 | $6,707,218.01 | -38.3% | -18.6% | -29.2% | |
| Sep 13, 2021 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sell | 36,055 | $35.22 | $1,269,949.80 | -8.7% | -9.2% | -27.1% | |
| Sep 2, 2021 | RAPT Rapt Therapeutics, Inc. | 10% Owner | Sell | 68,850 | $35.34 | $2,433,143.22 | -43.3% | -13.3% | -26.3% |